Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (311-320 of 511) with videos related to

Pageof 52
Sort By:
Journal of Hepatology|December 3, 2014
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Sonja Asmacher, Jennifer Lehmann, et al.
Hepatology (Baltimore, Md.)|July 23, 2022
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPSAlexander Queck, Louise Schwierz, Wenyi Gu, et al.
Zeitschrift Fur Gastroenterologie|January 11, 2021
Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow upLeon Louis Seifert, Dennis Görlich, Christian Jansen, et al.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 17, 2016
Statins improve NASH via inhibition of RhoA and RasRobert Schierwagen, Lara Maybüchen, Kanishka Hittatiya, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 27, 2019
Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPSMaria Torner, Adjmal Mangal, Hubert Scharnagl, et al.
Internal and Emergency Medicine|February 27, 2024
Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot studySimona Bartimoccia, Michael Praktiknjo, Cristina Nocella, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2025
Three-Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt DysfunctionCarsten Meyer, Markus Kimmann, Katharina Böhm, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2021
Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failureDelia Blaya, Elisa Pose, Mar Coll, et al.
Pageof 52

Showing results (311-320 of 511) with videos related to

Sort By:
Pageof 52
Journal of Hepatology|December 3, 2014
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Sonja Asmacher, Jennifer Lehmann, et al.
Hepatology (Baltimore, Md.)|July 23, 2022
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPSAlexander Queck, Louise Schwierz, Wenyi Gu, et al.
Zeitschrift Fur Gastroenterologie|January 11, 2021
Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow upLeon Louis Seifert, Dennis Görlich, Christian Jansen, et al.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 17, 2016
Statins improve NASH via inhibition of RhoA and RasRobert Schierwagen, Lara Maybüchen, Kanishka Hittatiya, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 27, 2019
Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPSMaria Torner, Adjmal Mangal, Hubert Scharnagl, et al.
Internal and Emergency Medicine|February 27, 2024
Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot studySimona Bartimoccia, Michael Praktiknjo, Cristina Nocella, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2025
Three-Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt DysfunctionCarsten Meyer, Markus Kimmann, Katharina Böhm, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2021
Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failureDelia Blaya, Elisa Pose, Mar Coll, et al.
Pageof 52